Sublethal Photodynamic Treatment Does Not Lead to Development of Resistance.

dc.contributor.author

Al-Mutairi, Rawan

dc.contributor.author

Tovmasyan, Artak

dc.contributor.author

Batinic-Haberle, Ines

dc.contributor.author

Benov, Ludmil

dc.date.accessioned

2020-07-15T22:28:32Z

dc.date.available

2020-07-15T22:28:32Z

dc.date.issued

2018-01

dc.date.updated

2020-07-15T22:28:30Z

dc.description.abstract

A promising new alternative approach for eradication of antibiotic-resistant strains is to expose microbes to photosensitizers, which upon illumination generate reactive oxygen species. Among the requirements for a potent, medically applicable photosensitizer, are high efficacy in killing microbes and low toxicity to the host. Since photodynamic treatment is based on production of reactive species which are potentially DNA damaging and mutagenic, it might be expected that under selective pressure, microbes would develop resistance. The aim of this study was to determine if antibacterial photodynamic treatment with a highly photoefficient photosensitizer, Zn(II) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin would lead to development of resistance. To answer that question, bacterial cultures were subjected to multiple cycles of sublethal photodynamic stress and regrowth, and to continuous growth under photodynamic exposure. Antibiotic-resistant Staphylococcus aureus and Escherichia coli clinical isolates were also tested for susceptibility to photodynamic inactivation and for development of resistance. Results demonstrated that multiple photodynamic exposures and regrowth of surviving cells or continuous growth under sublethal photodynamic conditions, did not lead to development of resistance to photosensitizers or to antibiotics. Antibiotic-resistant E. coli and S. aureus were as sensitive to photodynamic killing as were their antibiotic-sensitive counterparts and no changes in their sensitivity to antibiotics or to photodynamic inactivation after multiple cycles of photodynamic treatment and regrowth were observed. In conclusion, photosensitizers with high photodynamic antimicrobial efficiency can be used successfully for eradication of antibiotic-resistant bacterial strains without causing development of resistance.

dc.identifier.issn

1664-302X

dc.identifier.issn

1664-302X

dc.identifier.uri

https://hdl.handle.net/10161/21191

dc.language

eng

dc.publisher

Frontiers Media SA

dc.relation.ispartof

Frontiers in microbiology

dc.relation.isversionof

10.3389/fmicb.2018.01699

dc.subject

Zn porphyrin

dc.subject

antibiotic resistance

dc.subject

antimicrobial

dc.subject

photodynamic

dc.subject

photosensitizer

dc.title

Sublethal Photodynamic Treatment Does Not Lead to Development of Resistance.

dc.type

Journal article

pubs.begin-page

1699

pubs.organisational-group

School of Medicine

pubs.organisational-group

Radiation Oncology

pubs.organisational-group

Duke

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sublethal Photodynamic Treatment Does Not Lead to Development of Resistance.pdf
Size:
957.45 KB
Format:
Adobe Portable Document Format
Description:
Published version